… ProQR to Present at Two Upcoming Investor Conferences in … be accessible from the ‘Investor Relations’ section of ProQR’s website ( www.proqr.com ) under ‘Events and Presentations’. The …
… ProQR Announces Financial Results for the Second Quarter of … Mass., Aug. 07, 2019 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq:PRQR), a company dedicated to … progress towards accomplishing the goals set out in ProQR’s Vision 2023 strategy, which includes starting the …
… ProQR Announces Virtual Presentations at American Academy of … & CAMBRIDGE, Mass., Nov. 02, 2020 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq:PRQR), a company dedicated to … Academy of Ophthalmology (AAO) held November 13-15, 2020. ProQR’s presentations Presentation title: Phase 1b/2 trial …
… ProQR to Present at the RBC Capital Markets Healthcare … be accessible from the ‘Investor Relations’ section of ProQR’s website ( www.proqr.com ) under ‘Events and Presentations’. The …
… ProQR to Present at the JMP Securities Life Sciences … be accessible from the ‘Investor Relations’ section of ProQR’s website ( www.proqr.com ) under ‘Events and Presentations’. The …
Call on July 20 will include a snapshot from the ongoing InSight open-label extension study of sepofarsen, including preliminary second eye treatment data
… ProQR Prices $75 Million Underwritten Public Offering and … (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq: PRQR) (“ProQR”), a company dedicated to changing lives through … and commissions and other offering expenses payable by ProQR. All of the shares are being offered by ProQR. In …
… ProQR Strengthens Leading Intellectual Property Estate for … (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq: PRQR) (ProQR), a company dedicated to changing lives through … and Trademark Office (USPTO) granted a new patent to ProQR, under US patent No. 11,781,134 that relates to a …